Peregrine Pharmaceuticals (PPHM)

Add to Watchlists
Create an Alert
1.715 +0.03  +1.48% NASDAQ Apr 16, 12:18PM BATS Real time Currency in USD
View Full Chart
PPHM Price Chart
View All Events

PPHM Events

Date Type Description
Mar 07 Misc Peregrine Pharmaceuticals, Inc. Q3 2014 Earnings Conference Call
Mar 07 Earnings Peregrine Pharmaceuticals, Inc. Q3 2014 Earnings Results. Estimate: -0.07.
Dec 10 Misc Second Quarter Fiscal Year 2014 Financial Results Conference Call
Dec 10 Earnings Peregrine Pharmaceuticals Announces Upcoming Events. Estimate: -0.05.
Oct 17 Misc AGM Event for Peregrine Pharmaceuticals Inc
Sep 09 Misc Peregrine to Report First Quarter Fiscal Year 2014 Financial Call
Sep 09 Earnings Peregrine to Report First Quarter Fiscal Year 2014 Financial Results After Market Close on September 9, 2013. Estimate: -0.05.
Jul 11 Misc Peregrine Pharmaceuticals Fourth Quarter and Year-end Conference Call
Jul 11 Earnings Peregrine Pharmaceuticals Fourth Quarter and Year-end Earnings Results. Estimate: -0.07.
View All Performance Charts

PPHM Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Peregrine Pharmaceuticals is up 23.38% over the last year vs S&P 500 Total Return up 22.19%, Actelion up 73.17%, and Vanda Pharmaceuticals up 210.6%.

Get Quote for
Advertisement

Pro Strategies Featuring PPHM

Did Peregrine Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

PPHM Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: California
  • Current Fiscal Year End: April 30, 2014
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment and diagnosis of cancer.

Recent Quotes

Symbol Price Chg Chg % Market Cap
PPHM 1.715 +0.03 +1.48% 302.62M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.